Citation Impact
Citing Papers
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies
2008 Standout
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
2010 Standout
CD4+ Count–Guided Interruption of Antiretroviral Treatment
2006 Standout
Low Relative Skeletal Muscle Mass (Sarcopenia) in Older Persons Is Associated with Functional Impairment and Physical Disability
2002 Standout
A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance
2014 Standout
Plasma nevirapine levels, adverse events and efficacy of antiretroviral therapy among HIV-infected patients concurrently receiving nevirapine-based antiretroviral therapy and fluconazole
2007
Early Versus Delayed Antiretroviral Therapy and Cerebrospinal Fluid Fungal Clearance in Adults With HIV and Cryptococcal Meningitis
2013 StandoutNobel
Geriatric Nutritional Risk Index: a new index for evaluating at-risk elderly medical patients
2005 Standout
Efficacy and Safety of Atazanavir-Based Highly Active Antiretroviral Therapy in Patients with Virologic Suppression Switched from a Stable, Boosted or Unboosted Protease Inhibitor Treatment Regimen: The SWAN Study (AI424-097) 48-Week Results
2007
Microbiologic study of the pathogens isolated from wound culture among Wenchuan earthquake survivors
2009
Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy
2010
High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients
2008
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
2000 Standout
Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa
2007
Gemini: A Noninferiority Study of Saquinavir/Ritonavir Versus Lopinavir/Ritonavir as Initial HIV-1 Therapy in Adults
2009
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Cancer in patients on dialysis for end-stage renal disease: an international collaborative study
1999 Standout
Clinical management of tuberculosis and HIV-1 co-infection
2010
Early Immunologic Failure is Associated With Early Mortality Among Advanced HIV–Infected Adults Initiating Antiretroviral Therapy With Active Tuberculosis
2013 StandoutNobel
Crohn's disease
2012 Standout
Inflammation in Wound Repair: Molecular and Cellular Mechanisms
2007 Standout
A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney disease
2007 Standout
Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study
2015 StandoutNobel
Anti-Tuberculosis Drug Induced Hepatotoxicity among TB/HIV Co-Infected Patients at Jimma University Hospital, Ethiopia: Nested Case-Control Study
2013
Management of Cryptococcal Meningitis in Sub-Saharan Africa
2010
The gut microbiota of insects – diversity in structure and function
2013 Standout
Efavirenz in the therapy of HIV infection
2009
Administration of efavirenz (600 mg/day) with rifampicin results in highly variable levels but excellent clinical outcomes in patients treated for tuberculosis and HIV
2006
Methodological standards in non-inferiority AIDS trials: moving from adherence to compliance
2006
Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome
2015 StandoutNobel
Cryptococcosis
2006
Central Nervous System Aspergillosis
2012
A Prospective, Randomized Trial of Structured Treatment Interruption for Patients with Chronic HIV Type 1 Infection
2005
Identification of a new hemolysin from diarrheal isolate SSU ofAeromonas hydrophila
2007
Understanding the mechanisms and drivers of antimicrobial resistance
2015 Standout
Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy
2006
The end of AIDS: HIV infection as a chronic disease
2013 Standout
Clinical Pharmacokinetics and Summary of Efficacy and Tolerability of Atazanavir
2005
Age-Related Alterations in the Inflammatory Response to Dermal Injury
2001
Sequential Antibiotic Therapy: Effective Cost Management and Patient Care
1995
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
Reporting of adverse events in randomized controlled trials of highly active antiretroviral therapy: systematic review
2009
Monocyte Cytokine Production in an Elderly Population: Effect of Age and Inflammation
1998
Tuberculosis
2007
Age-related inflammatory cytokines and disease
2003
Strategies to Improve Long-Term Outcomes after Renal Transplantation
2002 Standout
Combination Antiviral Therapy for Ganciclovir‐Resistant Cytomegalovirus Infection in Solid‐Organ Transplant Recipients
2002
Surgical site infection due to Aeromonas species: Report of nine cases and literature review
2009
CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial
2006
Safety of Discontinuation of Maintenance Therapy for Disseminated Histoplasmosis after Immunologic Response to Antiretroviral Therapy
2004
Reporting of Noninferiority and Equivalence Randomized Trials
2012 Standout
The role of compartment penetration in PI-Monotherapy: the Atazanavir-Ritonavir Monomaintenance (ATARITMO) Trial
2007
Immunological recovery and antiretroviral therapy in HIV-1 infection
2006
Infection in Solid-Organ Transplant Recipients
2007 Standout
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation
2017 StandoutNobel
Immune Reconstitution Inflammatory Syndrome in HIV-Associated Cryptococcal Meningitis: A Prospective Study
2009
Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
2008 Standout
Efficacy and Safety of Atazanavir, With or Without Ritonavir, as Part of Once-Daily Highly Active Antiretroviral Therapy Regimens in Antiretroviral-Naive Patients
2008
Infection in Organ-Transplant Recipients
1998 Standout
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial
2013 Standout
Industry sponsorship and research outcome
2012 Standout
Outcomes of Nevirapine- and Efavirenz-Based Antiretroviral Therapy When Coadministered With Rifampicin-Based Antitubercular Therapy
2008
An Official American Thoracic Society Statement: Treatment of Fungal Infections in Adult Pulmonary and Critical Care Patients
2010
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Isolated antibody to hepatitis B core antigen in HIV-1 infected patients and a pilot study of vaccination to determine the anamnestic response.
2006
Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.
2009
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
Spontaneous fungal peritonitis: a rare but severe complication of liver cirrhosis
2017
Skeletal muscle mass and distribution in 468 men and women aged 18–88 yr
2000 Standout
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
2012 StandoutNobel
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
Biological basis of hypoalbuminemia in ESRD.
1998
Interaction between innate immune cells and a bacterial type III secretion system in mutualistic and pathogenic associations
2007
Thai national guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2010
2010
Assessment of Pathogens and Toxicants in New Orleans, LA Following Hurricane Katrina
2005
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
The Immune Response in Tuberculosis
2013 Standout
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
2010 Standout
The GenusAeromonas: Taxonomy, Pathogenicity, and Infection
2010 Standout
Factors Affecting Wound Healing
2010 Standout
Genome Sequence of Aeromonas hydrophila ATCC 7966 T : Jack of All Trades
2006
Hormones, Cytokines and Body Composition: Can Lessons from Illness be Applied to Aging?
1993
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries
2006
[Successful discontinuation of antifungal secondary prophylaxis in AIDS-related cryptococcosis].
2005
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
2010 Standout
Interruption of Antiretroviral Therapy and Risk of Cardiovascular Disease in Persons with HIV-1 Infection: Exploratory Analyses from the SMART Trial
2008
Hidden Killers: Human Fungal Infections
2012 Standout
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Clinical Practice Guidelines for the Management of Patients with Histoplasmosis: 2007 Update by the Infectious Diseases Society of America
2007 Standout
Industry sponsorship and research outcome
2017 Standout
Works of Asda Vibhagool being referenced
Initiation of antiretroviral therapy in advanced AIDS with active tuberculosis: clinical experiences from Thailand
2005
Nevirapine‐ versus efavirenz‐based highly active antiretroviral therapy regimens in antiretroviral‐naïve patients with advanced HIV infection
2004
Predictors of adherence and virologic outcome in HIV-infected patients treated with abacavir- or indinavir-based triple combination HAART also containing lamivudine/zidovudine
2004
Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trial
2003
Discontinuation of Secondary Prophylaxis for Cryptococcal Meningitis in Human Immunodeficiency Virus–Infected Patients Treated with Highly Active Antiretroviral Therapy: A Prospective, Multicenter, Randomized Study
2003
Efavirenz 600 mg/day versus efavirenz 800 mg/day in HIV-infected patients with tuberculosis receiving rifampicin: 48 weeks results
2005
The TREAT Asia HIV Observational Database
2005
Efavirenz levels and 24-week efficacy in HIV-infected patients with tuberculosis receiving highly active antiretroviral therapy and rifampicin
2005
Triple nucleoside treatment with abacavir plus the lamivudine/ zidovudine combination tablet (COM) compared to indinavir/COM in antiretroviral therapy-naïve adults: results of a 48-week open-label, equivalence trial (CNA3014)
2004
Skin and Soft-Tissue Infections among Tsunami Survivors in Southern Thailand
2005
Comparison of Once-Daily Atazanavir With Efavirenz, Each in Combination With Fixed-Dose Zidovudine and Lamivudine, As Initial Therapy for Patients Infected With HIV
2004
High-pressure liquid chromatography and microbiological assay of serum ofloxacin levels in adults receiving intravenous and oral therapy for skin infections
1991
Aspergillosis of the central nervous system: a catastrophic opportunistic infection.
2004
Monokine Production by Malnourished Nursing Home Patients
1990
Monokine Secretion in Aging and Protein Malnutrition
1989
Spontaneous cryptococcal peritonitis in cirrhotic patients.
2003
Risk factors for penicillin-resistant Streptococcus pneumoniae acquisition in patients in Bangkok.
2000
Initiation of highly active antiretroviral therapy in advanced AIDS with CD4 < 50 cells/mm3 in a resource-limited setting: efficacy and tolerability
2005
Prevalence of hepatitis B virus and hepatitis C virus co-infection with human immunodeficiency virus in Thai patients: a tertiary-care-based study.
2004
Virological and immunological responses of efavirenz-based HAART regimen initiated in HIV-infected patients at CD4 < 100 versus CD4 > or = 100 cells/mm3.
2006
Susceptibility of human cytomegalovirus to two-drug combinations in vitro.
1996